 |
Cyfuse Biomedical
Last updated: August 12, 2024
Koji Kuchiishi, CEO and President
Japan | Funding: $29.8M (+)
Website: http://www.cyfusebio.com/en/
We contribute to significant advances in medical treatments through our revolutionary 3D tissue-engineering technology. We successfully developed the BIO 3D PRINTER, Regenova. It is a state-of-the-art robotic system that enables fully automated fabrication of three-dimensional artificial tissues/organs from living cells.
Website: http://www.cyfusebio.com/en/
We contribute to significant advances in medical treatments through our revolutionary 3D tissue-engineering technology. We successfully developed the BIO 3D PRINTER, Regenova. It is a state-of-the-art robotic system that enables fully automated fabrication of three-dimensional artificial tissues/organs from living cells.
